Skip to content

Association between Serum Magnesium Disorders and Patient Prognosis

Association between Serum Magnesium Disorders and Patient Prognosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600128544
Enrollment
Unknown
Registered
2026-07-22
Start date
2026-07-31
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypomagnesemia

Interventions

Hypermagnesemia group:None
Hypomagnesemia group:None
Normal magnesium group:None

Sponsors

Xuanwu Hospital Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Admitted to Xuanwu Hospital, Capital Medical University from January 1, 2022 to December 31, 2024; 2.Aged >= 18 years; 3.No gender restriction; 4.Venous blood collected using red-top tubes (containing no additives) upon admission, and serum magnesium levels measured by chemical method; 5.Complete clinical data available (including but not limited to: demographic characteristics, admission information, comorbidities, surgical status, treatment modalities, prognostic information, laboratory results and testing times, etc.);

Exclusion criteria

Exclusion criteria: 1.Two or more hospital admissions; 2.Received magnesium supplementation before serum magnesium measurement;

Design outcomes

Primary

MeasureTime frame
In-hospital mortality;

Secondary

MeasureTime frame
Length of hospital stay;Utilization rate of antiarrhythmic drugs;

Countries

China

Contacts

Public ContactJiang Li

Xuanwu Hospital Capital Medical University

jiangli@sina.com+86 10 83922163

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026